Industries > Pharma > Global Vaccine Contract Manufacturing Market Report 2018-2028

Global Vaccine Contract Manufacturing Market Report 2018-2028

Leading Countries, Technologies and Companies

PUBLISHED: 06 March 2018
PAGES: 150
PRODUCT CODE: PHA0292

Clear
WOOCS 2.2.1

The global vaccine contract manufacturing market was worth $883.0m in 2017 and is expected to grow at a CAGR of 9.1% from 2017-2022. Visiongain predicts a CAGR of 9.2% for the global vaccine contract manufacturing market over the whole forecast period (2017-2028).
 
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 150-page report you will receive 69 charts– all unavailable elsewhere.

The 150-page report provides clear detailed insight into the global vaccine contract manufacturing market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

• Revenue and growth forecasts to 2028 for the global vaccine market and market shares in 2017 and 2018 of the submarkets: paediatric vaccines, adult vaccines, influenza vaccines and therapeutic vaccines

• Revenue and growth forecasts to 2028 for the global vaccine contract manufacturing market

• Revenue and growth forecasts to 2028 for the leading national markets:
• United States
• Germany
• France
• United Kingdom
• Italy
• Spain
• Japan
• Brazil
• Russia
• China
• India
• Rest of the World

Global Vaccine Contract Manufacturing Market Report 2018-2028

• Discussion and profiles of the leading players in the vaccine contract manufacturing market:
• Baxter BioPharma Solutions
• Boehringer Ingelheim
• Catalent
• Charles River Laboratories
• IDT Biologika
• Lonza
• Meridian Life Science
• Sigma Aldrich Fine Chemicals
• Merck
• Synco Bio Partners

• Analysis of what stimulates and restrains the global vaccine contract manufacturing market: Trends and SWOT Analysis

Visiongain’s study is intended for anyone requiring commercial analyses for the global vaccine contract manufacturing market. You find data, trends and predictions.

Buy our report today Global Vaccine Contract Manufacturing Market Report 2018-2028: Leading Countries, Technologies and Companies.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Vaccine Contract Manufacturing Market Report 2018-2028


Download sample pages

Complete the form below to download your free sample pages for Global Vaccine Contract Manufacturing Market Report 2018-2028


Latest Pharma news

Visiongain Publishes Pharmaceutical Product Information Management System Market Report 2020-2030

Some of the major factors fuelling the growth of global market include significant advantages associated with PIM solutions and inclination towards centralized models among across pharma sector.

19 October 2020

READ

Visiongain Publishes Pulmonary/Respiratory Drug Delivery Market Report 2020-2030

The coronavirus outbreak has negatively impacted all the economies and industries across the globe. Hence, for the next 1-2 years, the global respiratory drug delivery market is expected to take a hit.

12 October 2020

READ

Visiongain Publishes Real-World Evidence (RWE) Solutions Market Report 2020-2030

We predict strong revenue growth through to 2030. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

02 October 2020

READ

Visiongain Publishes mRNA Vaccines Market Report 2021-2031

The development of mRNA vaccines is driven by new biotechnologies and nanotechnologies. Emerging delivery technologies, such as electroporation (EP), innovative vaccine formats like mRNA preventive boost, and new molecular adjuvant technologies are particularly important for mRNA vaccines reaching their potential.

02 October 2020

READ

Categories

Category